pyrazines has been researched along with Iron Overload in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Chen, T; He, H; He, M; Hu, T; Li, H; Yang, B; Yin, D; Zhou, Q | 1 |
| Chen, SL; Guo, CY; Liu, X; Miao, Y; Sun, MY; Wang, JS; Yin, HJ; Zhang, M; Zhang, SP | 1 |
| Bernhardt, PV; Kalinowski, DS; Richardson, DR; Sharpe, PC | 1 |
3 other study(ies) available for pyrazines and Iron Overload
| Article | Year |
|---|---|
Tetramethylpyrazine alleviates iron overload damage in vascular endothelium via upregulating DDAHII expression.
Topics: Amidohydrolases; Apoptosis; Arginine; Cell Survival; Cells, Cultured; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Iron Overload; L-Lactate Dehydrogenase; Membrane Potential, Mitochondrial; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Pyrazines; Reactive Oxygen Species | 2020 |
The Influence of Hyperlipidemia on Endothelial Function of FPN1 Tek-Cre Mice and the Intervention Effect of Tetramethylpyrazine.
Topics: Animals; Antioxidants; Aorta; Cation Transport Proteins; Drugs, Chinese Herbal; Endothelial Cells; Female; Hepcidins; Hyperlipidemias; Iron Overload; Male; Mice, Inbred C57BL; Oxidative Stress; Pyrazines | 2018 |
Structure-activity relationships of novel iron chelators for the treatment of iron overload disease: the methyl pyrazinylketone isonicotinoyl hydrazone series.
Topics: Antineoplastic Agents; Ascorbic Acid; Benzoates; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Humans; Hydrazones; Hydroxylation; Iron; Iron Chelating Agents; Iron Overload; Iron Radioisotopes; Isonicotinic Acids; Ketones; Ligands; Oxidation-Reduction; Pyrazines; Structure-Activity Relationship | 2008 |